Pager Health, a connected health company that enables people to engage, navigate and access the right care in the right place at the right time, announced the appointment of clinician, operator and innovator Dr. Ken Yamaguchi as Chief Medical Officer. Dr. Yamaguchi will help bring clinical leadership, expertise and guidance to Pager Health’s product strategy, business development and care operations.
Health Technology Insights: Smart Meter Warns Against Sending RPM Data to China
“Dr. Yamaguchi brings more than 30 years of leadership at the intersection of clinical care, health system strategy, and medical innovation.” said Walter Jin, Chairman and CEO of Pager Health. “He played a pivotal role at Centene, helping scale the company by over $100 billion in revenue while overseeing approximately 1,000 personnel and indirectly guiding several thousand medical and affiliated staff. He now brings his cross-disciplinary background to Pager Health, where he will drive clinical innovation, deepen medical partnerships, and ensure the company’s solutions deliver measurable, real-world impact.”
Health Technology Insights: Ipsen Gets CHMP Nod for Cabometyx in Neuroendocrine Tumors
Dr. Yamaguchi is Professor of Orthopedic Surgery at Northwestern University Feinberg School of Medicine and previously served on Centene’s executive team (2015–2022), overseeing medical strategy during a period of rapid growth. Before that, he was the Sam and Marilyn Fox Distinguished Professor at Washington University and team physician for the St. Louis Cardinals. He holds a BA and MS from UCLA and an MBA from Washington University’s Olin School of Business. Dr. Yamaguchi has authored over 200 publications, delivered more than 70 visiting professorships at leading institutions including Johns Hopkins, Harvard, Penn, Brown, Dartmouth, Peking University, and Oxford, and is co-founder of Protera Health, a digital MSK provider.
He has also served on the executive committees of the American Orthopedic Association and American Shoulder and Elbow Surgeons, as deputy editor for the Journal of Bone and Joint Surgery, and on the board of directors of the American Academy of Orthopedic Surgeons.
Health Technology Insights: Abu Dhabi DoH and Abbott Partner for Local Drug Production
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
